Whole-body autoradioluminography (WBAL) has evolved as the preferred method for conducting tissue distribution studies that are required for regulatory filings of a new drug entity (DE) and for projecting tissue dosimetry in human mass balance studies. Four experiments were designed to assess WBAL utility using tritium as early as lead development in the drug discovery process. The objective of experiment 1 was to determine the minimum amount of tritium to administer to rats required for obtaining widespread distribution into most tissues at concentrations greater than quantification limits. Experiments 2, 3, and 4 were conducted to identify a tissue compartment responsible for observed triphasic pharmacokinetics, to characterize the distribution of a 
Widespread application of autoradiography within biological systems did not occur until the mid-to-late 1940s for several reasons. A need to develop efficient methodologies to measure the products of nuclear fission in plants and animals resulting from radioactive fallout was realized following the deployment of atomic weapons of mass destruction. Increasing numbers of methodologies were also successfully developed at this time for the synthesis of radiolabeled compounds that were of biological interest. The manufacture and application of liquid emulsion was first demonstrated in 1946 using histological specimens (Belanger and Leblond, 1946) . The consequence of these three events provided the foundation for liquid emulsion techniques that are still in use today (Joftes and Warren, 1955) . During this time, Sven Ullberg was interested in tracking the in vivo distribution of radiolabeled penicillin in mice by applying autoradiography using a novel whole-body cryosectioning technique (Ullberg, 1954 ). Ullberg's technique became known as whole-body autoradiography (WBA) and is the pharmaceutical industry standard for conducting preclinical tissue distribution studies (Solon and Kraus, 2002) . For pharmaceutical compounds in development, tissue distribution studies in animals are prerequisites to performing radiolabel studies in humans. Radiolabeled studies in humans are required for regulatory approval of drugs in many countries. For safety reasons, preclinical tissue distribution studies estimate the potential human organ exposures that support dosimetry calculations required by institutional review boards and regulatory authorities prior to administrating a radiolabeled compound to humans. A tissue distribution study assesses the time course elimination of radioactivity from tissues following the administration of a known quantity of radiolabeled compound. In drug discovery, preclinical distribution and pharmacokinetic parameters used for human dosimetry projections can also be utilized to evaluate a series of candidates where tissue exposure to a drug entity (DE) is relevant to the decision-making process for selecting a potential product for development.
The utilization of WBA in the drug discovery process has been severely limited by time constraints of film exposures. Until the early 1990s, the only practical method to detect radioactivity in whole-body cryosections was with X-ray film. X-ray film detection, although providing superior autoradiographs, is at best only semiquantitative due to the method's limited linearity resulting from saturation of the silver halide grains of the film (Som et al., 1983) . Also, X-ray film development may take more than 2 months (or more), simply because low levels of the radiolabeled compound in certain tissues require this amount of time to produce reliable data. Whole-body cryosections usually contain a wide range of radioactive concentrations. Thus, multiple exposure times, typically ranging from 2 weeks to 2 months, are required when using X-ray film to obtain semiquantitative data. Overexposures with X-ray film also require a new set of samples to be evaluated, which necessitate the acquisition of multiple samples from each study animal during the cryosectioning phase. Because of these factors, WBA studies using X-ray film typically take 3 to 9 months, which severely limit their utility in drug discovery. The second limiting factor for utilizing WBA is obtaining a radiolabeled compound early enough in the drug discovery process to provide data at crucial decision-making stages.
The development of the phosphorimager and storage phosphor plates provided an improved method to detect radioactivity in wholebody cryosections (Johnson et al., 1990) . Storage phosphor technology (i.e., autoradioluminography) has now replaced X-ray film (i.e., autoradiography) as the technology of choice in conducting wholebody autoradioluminography (WBAL) tissue distribution studies where quantification is mandatory. Quantification of [
14 C]radioactivity using this newer technology has been well documented and overcomes the severe limitations of X-ray film (Potchoiba et al., 1995 (Potchoiba et al., , 1998 . Whole-body cryosections containing tissues with a wide range of [
14 C]radioactivity concentrations can be readily quantified across a linear dynamic range of 1.6 to 36,000 nCi/g after one 4-day exposure. This significant reduction in exposure time has resulted in a study turnaround duration of 6 to 10 weeks for WBAL studies required for regulatory filing. The application of WBAL in the discovery process has been limited due mainly to the perception that WBAL (i.e., storage phosphor methodology) studies would be as time consuming as WBA (i.e., X-ray film-based) studies. The present experiments were designed to illustrate more rapid turnaround times for discoverybased WBAL studies, to determine quantification limits of the storage phosphor technology employing tritium, and to evaluate the overall utility of WBAL in the drug discovery process. (Kim et al., 2004) . The tritium exchange rate for the five radiochemicals utilized in this study was minimal.
Materials and Methods

Drug
When necessary, nonradiolabeled DEs were combined with their [ 3 H]DE counterparts to achieve the desired milligrams per kilogram and microcuries per kilogram doses. Nonradiolabeled DE compounds were synthesized by Pfizer Central Research chemists and were of the highest chemical purity achievable. All other reagents were of the highest obtainable commercial purity.
Animals. Jugular vein-cannulated Sprague-Dawley (SD) and Long-Evans rats were purchased from Charles River Laboratories (Raleigh, NC). Spontaneously hypertensive (SH) rats with indwelling jugular vein cannula were purchased from Taconic Farms (Germantown, NJ). The care of rats and treatment administration followed corresponded to the Animal Care and Use Procedures established at Pfizer. All rats were allowed to acclimate to environmental surroundings for 2 days prior to experimentation. Dosing solutions were intravenously administered through indwelling jugular vein cannula. Immediately following dose administration, sterile saline was used to flush residual dose from each cannula. Rats were individually housed in stainless steel metabolism cages. Feed and water were provided ad libitum throughout each experiment. All rats were euthanized by CO 2 asphyxiation at times specified below for each experiment.
WBAL. The whole-body cryosectioning technique developed by Ullberg (1977) was used to prepare whole-body cryosections from all experimental rats for autoradioluminography. Autoradioluminographic imaging and quantification methods for [
14 C]xenobiotics in whole-body cryosections described by Potchoiba et al. (1995) were employed for evaluating tissue concentrations of tritium with several notable modifications. For carbon-14 studies, a thin piece of Mylar film is typically applied over each sample to prevent contamination of the phosphorimager screens. The use of Mylar film with samples containing tritium must be avoided to prevent total quenching of the radioactive signal generated from the energy released during decay. Likewise, a suitable imaging plate for detecting tritium must also be utilized since the protective overcoat layer of cellulose acetate found on carbon-14 imaging screens is of sufficient thickness to totally prevent the capture of energy release by this weak ␤-emitter. Standard curve calibrators (STD) and cryosection quality control samples (CQCS) were freshly prepared with [ 3 H]glucose in rat control whole blood. STD and CQCS were independently prepared across a stepwise range of radioactivity concentrations. STD were necessary to construct the calibration curve for the quantification of [ 3 H]compounds present in tissues of wholebody digital images. CQCS were necessary to determine the limits of quantification for each experiment and to assess the quantification quality of the WBAL assay. For all experiments, STD and CQCS were embedded in the same carboxymethyl cellulose blocks as the specimens. Half of the study animals were embedded along with the STD; the remaining half from the same study were embedded along with the CQCS. Seven cryosections, each from 5 to 7 sectioning levels, were obtained from each rat based on sampling of all major tissues. Four cryosections from each sectioning level were apposed to Fuji imaging plates (BAS-TR2040; 20 ϫ 40 cm) (Fuji Medical Systems, Stamford, CT) for 17-day exposures. Each imaging plate contained two wholebody cryosections with STD and two whole-body cryosections with CQCS. This apposition procedure ensured that each imaging plate had its own calibration curve in duplicate while effectively assessing quantification with appropriate acceptance and rejection controls in the form of CQCS. All imaging plates were placed in a lead-and copper-lined cabinet to decrease background signals from environmental radiation. Imaging plates were scanned either with a 425F or STORM PhosphorImager (Amersham Biosciences). The MicroComputer Imaging Device (Imaging Research, St. Catharines, Ontario, Canada) was used to quantify the concentration of tritium in STD, CQCS, and tissues of whole-body cryosections for all experiments. Calibration curves for each tritium imaging plate were generated from the STD by weighted (1/x) linear regression analysis. The linear regression curve was then utilized to assess the radioactivity concentration in the CQCS and to determine the concentration of unknown radioactivity in the tissues of whole-body cryosection computerized images.
Pharmacokinetics. AUC (0-T last) and t 1/2 values were calculated from mean tissue levels using an in-house pharmacokinetics computer program (PK-PARAM). AUC (0-T last) values were calculated using linear trapezoidal approximation. The t 1/2 was calculated as the ln2/elimination rate constant (determined from the regression of the terminal phase tissue-radiolabeled material concentration). Experiment 1. 3 H]DE-1 (998 Ci/kg) was administered to five male SD rats weighing 210 to 250 g. Rats were prepared for WBAL analysis at 2, 12, 48, 96, and 168 h postdose (n ϭ 1 per time point). STD ranged in radioactivity from 31 to 19,800 nCi/g. Experiment 3. DE-2 was the lead candidate in its therapeutic class. The primary objectives of this experiment were to characterize the tissue distribution of this compound and to assess its distribution into brain tissues.
[ 3 H]DE-2 and nonradioactive DE-2 were codissolved in physiological saline to provide a concentration of 5 mg/ml. The radioactive potency of this dose was 1880 Ci/ml. Delivery volumes were adjusted from 0.18 to 0.20 ml in order for each rat to receive 5 mg/kg and 1880 Ci/kg [ 3 H]DE-2. The dosing volume was 1 ml/kg. Each Long-Evans male rat was euthanized by CO 2 asphyxiation at 0.25, 0.5, 1, 6, 12, and 24 h postdose (n ϭ 1 per time point) and prepared for WBAL analysis. STD ranged in radioactivity from 16 to 15,600 nCi/g and were embedded in the specimen blocks with the 0.25-, 0.5-, and 1-h rats. CQCS ranging in radioactivity from 29 to 14,200 nCi/g were embedded in the specimen blocks with the 6-, 12-, and 24-h rats.
Experiment 4. asphyxiation at 0.33 and 2 h postdose. STD ranged in radioactivity from 27 to 34,500 nCi/g and were embedded in the specimen blocks with the SD rats. CQCS ranging in radioactivity from 27 to 28,800 nCi/g were embedded in the specimen blocks with the SH rats.
Results
Calibration, Linear Dynamic Range, and Limits of Detection. Precision and accuracy were used as the fundamental criteria to determine the analytical error of the phosphorimager signals generated by the radioactivity concentrations of the STD and CQCS. Measurements of phosphorimager signals were considered acceptable if the radioactivity concentrations were within Ϯ20% of nominal concentrations. The relationship between the radioactivity concentration of each STD and the relative intensity of the phosphorimager signal is shown in Fig. 1 . Calibration curves for tritium imaging plates scanned with the 425F PhosphorImager were prepared over the concentration range of 5 to 1.9 ϫ 10 6 nCi/g. Two of the five STD representing the lowest radioactivity concentrations (5 and 10 nCi/g) did not elicit a phosphorimager signal. Precision and accuracy for the 19, 38, and 68 nCi/g STD were above the 20% acceptable limits and excluded from the standard curves. Precision and accuracy of five additional STD of radioactivity concentrations in the range of 110,000 to 1,900,000 nCi/g were greater than 20% of nominal concentrations and consequently disqualified based upon the failure to meet this acceptance criterion. Curve fitting of these STD obtained from 16 imaging plates after 17-day exposures by weighted (1/x) linear regression resulted in a mean correlation coefficient (r) of 0.998 Ϯ 0.002. Precision for the STD ranged from 11 to 19%. Accuracy for these same STD was calculated to be in the range of 89 to 117% of nominal concentrations. Sixteen CQCS having radioactivity concentrations from 7 to 68,400 nCi/g were used to assess the quality and acceptability of this analytical method (Table 1) . At the three lowest concentrations of 7, 9, and 11 nCi/g, digital images of the expected radioactive patterns were not observed on any autoradioluminogram obtained with the 425F PhosphorImager. Precision of the highest radioactivity concentration (68,400 nCi/g) was 12% and met acceptance criteria. However, accuracy of this CQCS did not satisfy acceptance criteria, indicating that the upper limit of quantification was between 37,500 and 68,400 nCi/g. For experiments 1 and 2 involving the 425F PhosphorImager, the linear dynamic range of the STD was 120 to 59,000 nCi/g. The lower limit of quantification based upon CQCS evaluation was 127 nCi/g. These weighted (1/x) linear regression calibration curve and CQCS parameters were then utilized to determine the concentrations of unknown radioactivity in tissues of whole-body cryosection digital images from rats administered . Accuracy for these same STD ranged from 89 to 107% of nominal concentrations. Three STD representing the lowest radioactivity concentrations of 16, 27, and 30 nCi/g were excluded from the calibration curves, because either the precision or accuracy was Ϯ20% of nominal concentrations. Precision and accuracy for STD of the greatest radioactivity concentrations were well within acceptable limits and consequently included in the calibration curves for experiments 3 and 4. For the two experiments involving the STORM PhosphorImager, the linear dynamic range was 47 to 16,000 nCi/g and 54 to 34,500 nCi/g for experiments 3 and 4, respectively. The lower limit of quantification based upon CQCS evaluation was 54 nCi/g for experiment 3 and 72 nCi/g for experiment 4 ( 3 H]glucose radioactivity was lower in the heart, kidney, pancreas, salivary gland, skin, spleen, and thymus than that noted for systemic blood and central nervous system (CNS) tissues. Liver and lung concentrations of [ 3 H]glucose radioactivity appeared to be similar to that of systemic blood and CNS tissues. In addition to the eye, only the Harderian gland and intestinal mucosa had a greater uptake of [ 3 H]glucose radioactivity than systemic blood and CNS tissues, except at the dose of 4320 Ci/kg for the Harderian gland. The uptake of [ 3 H]glucose in most tissues appeared to be proportional to the amount administered up to 2360 Ci/kg. At 4320 Ci/kg, [ 3 H]glucose uptake into tissues continued to increase but was no longer proportional to the increase in dosage. Increasing the dose from 2360 to 4320 Ci/kg (1.8-fold) increased the concentration of radioactivity in tissues only by 1.3-fold. For muscle, this increase in dose resulted in concentrations that were similar to those at 2360 Ci/kg. Concentrations of [ 3 H]glucose were quantifiable in the cerebellum, cerebrum, medulla oblongata, and spinal cord of all four rats at 15 min postdose, regardless of dose. Mean brain to (Fig. 2) . At a dose of 865 Ci/kg, all tissues except muscle were shown to uptake [ 3 H]glucose radioactivity in quantifiable amounts. It appears from our investigation that the minimum amount of tritium necessary to investigate the tissue distribution of [ 3 H]DE in rats using WBAL was a dose of 865 Ci/kg, whereas a dose of 2360 Ci/kg provided excellent qualitative visualization of [ 3 H]radioactivity distribution (Fig. 3) .
Experiment 2. Mean radioactivity values were calculated by averaging 1) tissue concentrations measured at different sectioning levels and/or 2) tissue concentrations measured from replicate cryosections obtained from the same sectioning level; n values range from a minimum of 3 to a maximum of 12. 3 H]DE-2 declined between 1 and 12 h, the 24-h concentration was similar to 12-h levels.
The t 1/2 of [ 3 H]radioactivity measured for five brain tissues ranged from 2.9 to 6.9 h (mean, 4.8 h). Radioactivity was eliminated from whole blood with a t 1/2 of 3.6 h. Based on AUC (0-T last) , the cerebrum to whole-blood ratio was 20. These WBAL findings provided visual and quantitative confirmation that [ 3 H]DE-2 distributed into brain tissues following intravenous administration (Fig. 4) .
[ in the samples being analyzed. The inclusion of CQCS provides a quantitative measurement of sensitivity and the foundation for determining the error associated with the storage phosphor technology. Calculating the accuracy and precision of quality control samples assesses the quality of any analytical method. In this study, CQCS were used to monitor the quality of the storage phosphor calibration curve. The 425F PhosphorImager calibration curves for experiment 1 were prepared over a dynamic range that spanned 7 orders of magnitude (5 to 1.9 ϫ 10 6 nCi/g). The linear response of these STD was limited to 3 orders of magnitude encompassing 120 to 59,000 nCi/g. The quality of these curves was evaluated with CQCS that covered a radioactivity range of 7 to 68,400 nCi/g. CQCS response verified the linearity, reproducibility, limit of quantification, and ruggedness of 17 calibration curves. Based upon this CQCS response, the working linear dynamic range of the 425F PhosphorImager calibration curves was constrained from 127 to 37,500 nCi/g. High background levels resulting from cosmic and environmental radiation over the 17-day exposure period influenced the lower limit of quantification. The upper limit of quantification was restricted for the following reason: at high concentrations of radioactivity, the 425F PhosphorImager generates flare. Increases in radioactivity concentration results produce a proportional increase in flare production. Flare is due to stray laser light generated after striking high-intensity signals on the imaging plate. It is characterized on digital images by a halo effect surrounding the target tissue and causes a loss of clarity of well-defined boundaries between tissues. The intensity of flare signals can obliterate the observation of an entire tissue in close proximity to the signal causing the flare event. Consequently, the ability to quantify the radioactivity in tissues covered with flare becomes impossible, and valuable tissue distribution data are lost. The necessity of a 17-day exposure to maximize the lower limit of quantification also allows for the generation of increased flare intensity and a nonlinear response at the upper limits of quantification. The results of this validation of the tritium WBAL assay developed the calibration and CQCS foundation for experiments 2, 3, and 4. In addition, to reduce flare intensity, the STD of high radioactivity was restricted to 19,800 nCi/g for experiment 2. Nominal concentrations of tritium radioactivity for the high STD for experiments 3 and 4 were limited to 14,200 and 28,800 nCi/g, respectively.
The STORM PhosphorImager response to tritium revealed improvements in quantification compared with that observed for the 425F PhosphorImager. The dynamic range was still limited to 3 orders of magnitude, but a lower quantification limit was obtained in experiments 3 (54 nCi/g) and 4 (72 nCi/g). This improvement in response may be attributed to the redesigned mechanical operations of the scanning laser beam and scanner platform resulting in lower background readings and a significant reduction of flare generation for the STORM PhosphorImager. These modifications were responsible for an average 2-fold increased sensitivity as realized by an improved lower limit of quantification over the results obtained with the 425F PhosphorImager. The use of CQCS ensured that any variation in obtaining cryosections of the specimens would also be reflected in the phosphorimager signal produced by the CQCS. Variations in section thickness would produce similar variations in the intensity of the phosphorimager signal. The greater the variation in section thickness, the greater the deviation will be from the expected nominal concentration of radioactivity. Thus, the inclusion of CQCS in the same block as the specimens was an appropriate measure of accuracy and precision for testing the validity and quality of this WBAL analytical method.
The results of these experiments illustrated that a good linear correlation exists between the concentration of tritium radioactivity and the PhosphorImager response. In comparison, the STORM PhosphorImager has a lower limit of quantification of 1.6 nCi/g for carbon-14 and a linear dynamic range that expands across 4 orders of magnitude (i.e., 1.6 -39,000 nCi/g). Based upon the lower quantification limits, WBAL analysis employing tritium appears to be at least 35-fold less sensitive than that observed for carbon-14.
The length of the WBAL study was shown to be dependent on the objectives of the study. In experiment 2, for example, which was designed to determine distribution to a deep compartment and for which the use of CQCS was not necessary, exposure was held constant at 17 days, and the study was successfully completed in 32 days. In comparison, experiment 3 was conducted to characterize the distribution of a lead discovery candidate, particularly to assess its ability to distribute into brain tissues. Since the study design primarily required the use of CQCS, 38 days were required to complete this experiment. In contrast, 45 days were required to complete experiment 4, in which the disposition of two discovery compounds in two different rat strains was assessed.
A comparison of study lengths between WBAL and WBA experiments employing tritium demonstrates that the amount of time required to complete a WBAL study was always less than the 2 or 3 months typically required just for exposure of samples to X-ray films in WBA studies. The results of these three experiments clearly illustrated that the application of storage phosphor technology (i.e., WBAL) in the discovery process required significantly less time (greater than 2-fold) than those studies using X-ray film (i.e., WBA) as the medium to capture data. Utilization of WBAL to address specific discovery issues to aid in the selection of a candidate for full development was accomplished in a timely and efficient manner while generating useful quantitative data. To decrease the WBAL study turnaround time even further, the 17-day exposure time can be shortened provided that the lower quantification limit can be sacrificed without jeopardizing the objectives of the experiment. Shimada et al. (1976) reported the uptake of [U-14 C]glucose in albino mice at 30 min after an intraperitoneal injection was greatest in 14 C]DE. Typically, a tritium synthesis on average can be completed in about 3 weeks while achieving a [ 3 H]DE with a radiochemical purity of Ͼ95%. The synthesis of a [ 14 C]DE requires a minimum of 3 months. Since the preparation of radiolabeled test materials is a major gating factor in study turnaround, the use of tritium is key to the timely completion of experiments in the discovery setting. These WBAL experiments have demonstrated that the use of tritium can play a significant role in the discovery process for new drugs. In programs where the distribution of the drug to target tissues is an issue, resolution is achievable within a 2-month time frame using tritium as opposed to a minimum of 5 months for WBAL studies using carbon-14 when factoring in the time required to synthesize these radiochemicals.
